You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -113.2% | -35.2% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -2.4 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 4.6 | 3.5 |
Price / Book value | 2.5 |
Latest | Forecast | |
---|---|---|
Revenue | 8.0% | -7.6% |
PBT | 0.0% | n/a |
EPS | 0.0% | -2.5% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 0.01 | -18.62 | -12.54p | -13.9 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 9.43 | -23.46 | -12.54p | -14.9 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 25.16 | -30.34 | -14.48p | -9.9 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 27.17 | -30.98 | -14.48p | -1.7 | 0.0 | n/a | n/a | 0.0% |
Creo device used in 'groundbreaking' lung cancer procedure Sharecast News | 01 Mar |
---|---|
Creo Medical FY revenues up double digits Sharecast News | 07 Feb |
Creo launches 'Speedboat Ultraslim' with first UK procedure Sharecast News | 13 Dec |
Holding(s) in Company | 20-Mar-24 16:53 |
---|---|
Holding(s) in Company | 13-Mar-24 15:07 |
LTIP Awards | 11-Mar-24 15:26 |
Holding(s) in Company | 06-Mar-24 16:40 |
Trading Update - Replacement | 07-Feb-24 09:14 |